Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
DLB US​

Dolby Laboratories, Inc. Class A(DLB US)

$62.85-0.430.68%Ext:$62.25-0.600.95%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings

Financials(88)

Expand
  • 10-QQ3ended 26 Jun 202630 Jul
  • 10-QQ2ended 27 Mar 202630 Apr
  • 10-QQ1ended 26 Dec 202529 Jan
  • 10-KFY 2025ended 26 Sept 202518 Nov 2025
  • 10-QQ3ended 27 Jun 202531 Jul 2025
  • 10-QQ2ended 28 Mar 20251 May 2025
  • 10-QQ1ended 27 Dec 202430 Jan 2025
  • 10-KFY 2024ended 27 Sept 202419 Nov 2024
  • 10-QQ3ended 28 Jun 20247 Aug 2024
  • 10-QQ2ended 29 Mar 20242 May 2024
  • 10-QQ1ended 29 Dec 20232 Feb 2024
  • 10-KFY 2023ended 29 Sept 202317 Nov 2023
  • 10-QQ3ended 30 Jun 20233 Aug 2023
  • 10-QQ2ended 31 Mar 20235 May 2023
  • 10-QQ1ended 30 Dec 20222 Feb 2023

Events(190)

Expand
  • 8-KDolby Laboratories Announces Leadership Transition27 Aug
  • 8-KDolby Laboratories Reports Third Quarter 2026 Financial Results30 Jul
  • 8-KDolby Laboratories Reports Second Quarter 2026 Financial Results30 Apr
  • 8-KSubmission of Matters to a Vote of Security Holders6 Feb
  • 8-KDolby Laboratories Reports First Quarter 2026 Financial Results29 Jan
  • 8-KDolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial18 Nov 2025
  • 8-K2026 DOLBY EXECUTIVE BONUS PLAN14 Nov 2025
  • 8-KDolby Laboratories Reports Third Quarter 2025 Financial Results31 Jul 2025
  • 8-KDolby Laboratories Reports Second Quarter 2025 Financial Results1 May 2025
  • 8-KCharter/Bylaw Amendment; Fiscal Year Change7 Feb 2025
  • 8-KDolby Laboratories Reports First Quarter 2025 Financial Results29 Jan 2025
  • 8-KDolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results19 Nov 2024
  • 8-K2025 DOLBY EXECUTIVE BONUS PLAN15 Nov 2024
  • 8-KOther Events19 Aug 2024
  • 8-KDolby Laboratories Reports Third Quarter 2024 Financial Results7 Aug 2024

Insider Ownership(1.7K)

Expand
  • 4Statement of changes in beneficial ownership5 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership17 Sep
  • 4Statement of changes in beneficial ownership17 Sep
  • 4Statement of changes in beneficial ownership17 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 4Statement of changes in beneficial ownership28 Aug
  • 3Initial statement of beneficial ownership28 Aug
  • 4Statement of changes in beneficial ownership27 Aug
  • 4Statement of changes in beneficial ownership18 Aug
  • 4Statement of changes in beneficial ownership12 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership5 Aug
  • 4Statement of changes in beneficial ownership6 Jul
  • 4Statement of changes in beneficial ownership3 Jun

Beneficial Ownership(170)

Expand
  • SC 13G/ADolby Laboratories, Inc.22 Oct
  • SC 13G/ADolby Laboratories, Inc.4 Jun
  • SC 13G/ADolby Laboratories, Inc.11 May
  • SC 13GDolby Laboratories, Inc.29 Apr
  • SC 13GDolby Laboratories, Inc.29 Apr
  • SC 13G/ADolby Laboratories, Inc.28 Apr
  • SC 13G/ADolby Laboratories, Inc.26 Mar
  • SC 13D/ADolby Laboratories, Inc.13 Feb
  • SC 13G/ADolby Laboratories, Inc.11 Feb
  • SC 13G/ADolby Laboratories, Inc.30 Apr 2025
  • SC 13G/ADolby Laboratories, Inc.21 Apr 2025
  • SC 13D/ADolby Laboratories, Inc.3 Feb 2025
  • SC 13GDolby Laboratories, Inc.23 Jan 2025
  • SC 13G/ADolby Laboratories, Inc.13 Nov 2024
  • SC 13G/ADolby Laboratories, Inc.10 Sep 2024

Other Ownership(68)

Expand
  • 144Couling John D1 Oct
  • 144Couling John D1 Sep
  • 144Nicholson Ryan25 Aug
  • 144Revankar Shriram14 Aug
  • 144Nicholson Ryan10 Aug
  • 144Couling John D3 Aug
  • 144Couling John D1 Jul
  • 144Couling John D1 Jun
  • 144Pendleton Todd22 May
  • 144Revankar Shriram15 May
  • 144Park Robert J12 May
  • 144Couling John D5 May
  • 144Couling John D4 May
  • 144Rollins Emily1 Apr
  • 144Revankar Shriram17 Feb

Proxies(55)

Expand
  • ARSAnnual report to security holders16 Dec 2025
  • DEFA14ADefinitive additional materials16 Dec 2025
  • DEF 14ADefinitive proxy statement16 Dec 2025
  • DEFA14ADefinitive additional materials20 Dec 2024
  • DEF 14ADefinitive proxy statement20 Dec 2024
  • ARSAnnual report to security holders20 Dec 2024
  • PRE 14APreliminary proxy statement10 Dec 2024
  • ARSAnnual report to security holders22 Dec 2023
  • DEF 14ADefinitive proxy statement22 Dec 2023
  • DEFA14ADefinitive additional materials22 Dec 2023
  • PRE 14APreliminary proxy statement12 Dec 2023
  • DEF 14ADefinitive proxy statement19 Dec 2022
  • DEFA14ADefinitive additional materials19 Dec 2022
  • DEFA14ADefinitive additional materials17 Dec 2021
  • DEF 14ADefinitive proxy statement17 Dec 2021

Registrations(23)

Expand
  • S-8Registration statement (employee benefit plan)11 Sep
  • S-8Registration statement (employee benefit plan)25 Feb 2020
  • S-8Registration statement (employee benefit plan)14 Feb 2017
  • S-8Registration statement (employee benefit plan)11 Feb 2015
  • S-8Registration statement (employee benefit plan)14 May 2013
  • S-8Registration statement (employee benefit plan)18 May 2011
  • S-8Registration statement (employee benefit plan)9 May 2008
  • 424B7Prospectus filing (Rule 424(b)(7))24 May 2007
  • 424B2Prospectus filing (Rule 424(b)(2))15 May 2007
  • S-3ASRAutomatic shelf registration statement (S-3)15 May 2007
  • 8-A12GREGISTRATION OF A CLASS OF SECURITIES PURSUANT TO SECTION 12(G)25 Jan 2006
  • S-8Registration statement (employee benefit plan)18 Feb 2005
  • 424B4FILED PURSUANT TO RULE 424(B)(4)17 Feb 2005
  • S-1/AAMENDMENT #5 FOR DOLBY LABORATORIES16 Feb 2005
  • RWRegistration withdrawal request15 Feb 2005

Filing Review Correspondence(12)

Expand
  • CORRESPFiling review correspondence11 Mar 2024
  • CORRESPFiling review correspondence14 Mar 2018
  • CORRESPFiling review correspondence2 Mar 2016
  • CORRESPFiling review correspondence3 Feb 2016
  • CORRESPFiling review correspondence11 Feb 2015
  • UPLOADFiling review upload28 Apr 2009
  • CORRESPFiling review correspondence14 Apr 2009
  • UPLOADFiling review upload1 Apr 2009
  • CORRESPFiling review correspondence24 Mar 2009
  • UPLOADFiling review upload10 Mar 2009
  • CORRESPFiling review correspondence24 Feb 2009
  • UPLOADFiling review upload10 Feb 2009

SEC Orders And Notices(4)

Expand
  • 40-APP/AAMENDMENT NO. 3 TO APPLICATION FOR AN ORDER PURSUANT TO SECTION 3(B)(2)30 Sep 2010
  • 40-APP/AAMENDMENT NO. 2 TO APPLICATION FOR AN ORDER PURSUANT TO SECTION 3(B)(2)22 Apr 2010
  • 40-APP/AAMD. NO. 1 TO APPLICATION FOR ORDER PURSUANT TO SECTION 3(B)(2) OF THE 1940 ACT7 Apr 2009
  • 40-APPAUTO-GENERATED PAPER DOCUMENT26 Sep 2008

Tender Offers And Going Private(6)

Expand
  • SC TO-I/AAMENDMENT NO. 3 TO SCHEDULE TO14 Aug 2012
  • SC TO-I/AAMENDMENT NO. 2 TO SCHEDULE TO10 Aug 2012
  • SC TO-I/AAMENDMENT NO. 1 TO SCHEDULE TO9 Aug 2012
  • SC TO-ISCHEDULE TO16 Jul 2012
  • SC TO-CSCHEDULE TO9 Feb 2012
  • SC TO-CSCHEDULE TO14 Dec 2011

Other(16)

Expand
  • SDSD29 May
  • SDSD29 May 2025
  • SDSD30 May 2024
  • SDSD24 May 2023
  • SDSD26 May 2022
  • SDSD27 May 2021
  • SDSD28 May 2020
  • SDSD30 May 2019
  • SDSD24 May 2018
  • SDSD25 May 2017
  • SDSD27 May 2016
  • SDSD27 May 2015
  • SDSD2 Jun 2014
  • APP ORDRAPP ORDR7 Nov 2010
  • APP NTCAPP NTC5 Oct 2010

Financials & Metrics

FinancialsChartingShort InterestEmployees